Ms Lisa Michelle Dymond, MS CCC-SLP is a
Speech-language Pathologist based in Churchville, Maryland. Ms Lisa Michelle Dymond is licensed to practice in Maryland (license number 07609) and her current practice location is
124 Goucher Way, Churchville, Maryland. She can be reached at her office (for appointments etc.) via phone at
(410) 937-3338.
NPI number for Ms Lisa Michelle Dymond is 1003479734 and her current mailing address is 1000 S Marlyn Ave, Baltimore, Maryland. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1003479734.
Healthcare Provider's Profile
Full Name | Ms Lisa Michelle Dymond |
---|
Gender | Female |
---|
Speciality | Speech-language Pathologist |
---|
Location | 124 Goucher Way, Churchville, Maryland |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1003479734
- Provider Enumeration Date: 04/18/2019
- Last Update Date: 04/18/2019
Medical Identifiers
Medical identifiers for Ms Lisa Michelle Dymond such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1003479734 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
235Z00000X | Speech-language Pathologist | 07609 (Maryland) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ms Lisa Michelle Dymond is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Ms Lisa Michelle Dymond, MS CCC-SLP 1000 S Marlyn Ave, Baltimore, MD 21221-5999 Ph: (410) 887-0112 | Ms Lisa Michelle Dymond, MS CCC-SLP 124 Goucher Way, Churchville, MD 21028-1218 Ph: (410) 937-3338 |
Reviews and Comments